Takhzyro Europeiska unionen - norska - EMA (European Medicines Agency)

takhzyro

takeda pharmaceuticals international ag ireland branch - lanadelumab - angioødemer, arvelig - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.

Alunbrig Europeiska unionen - norska - EMA (European Medicines Agency)

alunbrig

takeda pharma a/s - brigatinib - karsinom, ikke-småcellet lunge - antineoplastiske midler - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.

Livtencity Europeiska unionen - norska - EMA (European Medicines Agency)

livtencity

takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovirusinfeksjoner - antivirale midler til systemisk bruk - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). det bør vurderes å offisielle retningslinjer for riktig bruk av antivirale midler.

Pantecta Control Europeiska unionen - norska - EMA (European Medicines Agency)

pantecta control

takeda gmbh - pantoprazol - gastroøsofageal refluks - proton pumpen inhibitors - kortsiktig behandling av reflukssymptomer (f.eks. halsbrann, syreregurgitasjon) hos voksne.

Ceprotin Europeiska unionen - norska - EMA (European Medicines Agency)

ceprotin

takeda manufacturing austria ag - humant protein c - purpura fulminans; protein c deficiency - antithrombotic agents - ceprotin is indicated for prophylaxis and treatment of  purpura fulminans  coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.

Albyl-E 160 mg Norge - norska - Statens legemiddelverk

albyl-e 160 mg

takeda as - acetylsalisylsyre - enterotablett - 160 mg

Nycoplus B-Tonin 0.3 mg/ ml / 1 mg/ ml / 1.45 mg/ ml / 0.1 mg/ ml / 0.1 mg/ ml / 0.15 mg/ ml Norge - norska - Statens legemiddelverk

nycoplus b-tonin 0.3 mg/ ml / 1 mg/ ml / 1.45 mg/ ml / 0.1 mg/ ml / 0.1 mg/ ml / 0.15 mg/ ml

takeda as - dekspantenol / nikotinamid / koffein / tiaminhydroklorid / pyridoksinhydroklorid / riboflavinnatriumfosfat - mikstur, oppløsning - 0.3 mg/ ml / 1 mg/ ml / 1.45 mg/ ml / 0.1 mg/ ml / 0.1 mg/ ml / 0.15 mg/ ml

Nycoplus B-Total 1.5 mg / 2 mg / 2 mg / 3 mg / 10 mg Norge - norska - Statens legemiddelverk

nycoplus b-total 1.5 mg / 2 mg / 2 mg / 3 mg / 10 mg

takeda as - vitamin b1 / vitamin b2 / vitamin b6 / kalsiumpantotenat / nikotinamid - tablett, filmdrasjert - 1.5 mg / 2 mg / 2 mg / 3 mg / 10 mg

Nycoplus Calcigran 500 mg / 200 IE Norge - norska - Statens legemiddelverk

nycoplus calcigran 500 mg / 200 ie

takeda as - kalsiumkarbonat / kolekalsiferol - tyggetablett - 500 mg / 200 ie

Nycoplus C-vitamin 250 mg Norge - norska - Statens legemiddelverk

nycoplus c-vitamin 250 mg

takeda as - askorbinsyre - tablett - 250 mg